JAZZ vs VERO · P/E 1988, rev $2.28B vs rev $64.8M
Jazz Pharmaceuticals PLC (JAZZ) versus Venus Concept Inc (VERO) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Venus Concept Inc (VERO) is a medical devices company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported VERO revenue for 2024-12-31 was $64.8M. Net income was -$47.0M. Revenue was down 15.1% from 2023-12-31 to 2024-12-31. VERO currently screens at market cap $578.2K.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. VERO currently screens at market cap $578.2K.
Not investment advice. Open the JAZZ and VERO stock pages for the full models.
Not investment advice.